✦ LIBER ✦

Combination therapy with ribavirin and interferon in naive patients with chronic hepatitis C without virological response after two months of interferon therapy. Preliminary results

✍ Scribed by F Lunel; P Cresta

Book ID: 118568715
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 173 KB
Volume: 28
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(98)80948-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon and thymosin combination ther

Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: preliminary results

✍ S. Moscarella; G. Buzzelli; R. G. Romanelli; M. Monti; C. Giannini; G. Careccia; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB

Response to combination therapy with int

Response to combination therapy with interferon and ribavirin in hepatitis C cirrhotic patients

✍ R Pena; V Kaul; A Suvannasankha; K DiGregorio; L Stein; F Gross; S Peikin; O Per 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 33 KB

Effect of lactoferrin in patients with c

Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin

✍ Masahiko Kaito; Motoh Iwasa; Naoki Fujita; Yoshinao Kobayashi; Yuji Kojima; Jiro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Ribavirin and interferon -alfa combined

Ribavirin and interferon -alfa combined therapy in relapsed patients with chronic hepatitis C

✍ G. Lengyel; T. Bálint; J. Fehér 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Combination therapy with interferon-α an

Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C

✍ Norio Horiike; Morikazu Onji 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 132 KB

Limitation of combination therapy of int

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a